Maslinic acid prevents IL‐1β‐induced inflammatory response in osteoarthritis via PI3K/AKT/NF‐κB pathways

Osteoarthritis (OA) is a degenerative joint disease characterized by destruction of articular cartilage. The inflammatory response is the most important factor affecting the disease process. As interleukin‐1β (IL‐1β) stimulates several key mediators in the inflammatory response, it plays a major rol...

Full description

Saved in:
Bibliographic Details
Published inJournal of cellular physiology Vol. 236; no. 3; pp. 1939 - 1949
Main Authors Chen, Yan‐Lin, Yan, De‐Yi, Wu, Chen‐Yu, Xuan, Jiang‐Wei, Jin, Chen‐Qiang, Hu, Xin‐Li, Bao, Guo‐Dong, Bian, Yu‐Jie, Hu, Zhi‐Chao, Shen, Zhong‐Hai, Ni, Wen‐Fei
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.03.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Osteoarthritis (OA) is a degenerative joint disease characterized by destruction of articular cartilage. The inflammatory response is the most important factor affecting the disease process. As interleukin‐1β (IL‐1β) stimulates several key mediators in the inflammatory response, it plays a major role in the pathogenesis of OA. Maslinic acid (MA) is a natural compound distributed in olive fruit. Previous studies have found that maslinic acid has an inhibitory effect on inflammation, but its specific role in the progression of OA disease has not been studied so far. In this study, we aim to assess the protective effect of MA on OA progression by in vitro and in vivo experiments. Our results indicate that, in IL‐1β‐induced inflammatory response, MA is effective in attenuating some major inflammatory mediators such as nitric oxide (NO) and prostaglandin E2, and inhibits the expression of IL‐6, inducible nitric oxide synthase, cyclooxygenase‐2, and tumor necrosis factor‐α (TNF‐α) in a concentration‐dependent manner. Also, MA downregulated the expression levels of thrombospondin motif 5 (ADAMTS5) and matrix metalloproteinase 13 in chondrocytes, resulting in reduced degradation of its extracellular matrix. Mechanistically, MA exhibits an anti‐inflammatory effect by inactivating the PI3K/AKT/NF‐κB pathway. In vivo, the protective effect of MA on OA development can be detected in a surgically induced mouse OA model. In summary, these findings suggest that MA can be used as a safe and effective potential OA therapeutic strategy. Maslinic acid (MA) could prevent IL‐1β‐associated inflammation as well as extracellular matrix (ECM) degradation in human osteoarthritis (OA) chondrocytes. The potential mechanism involved in the protective effect of MA was that it could reverse inflammation‐related destruction via inhibiting PI3K/AKT/NF‐κB pathways activation. MA ameliorates OA progression in vivo via inhibiting the devastation of cartilage surface, cartilage calcification, and osteophytes formation.
AbstractList Osteoarthritis (OA) is a degenerative joint disease characterized by destruction of articular cartilage. The inflammatory response is the most important factor affecting the disease process. As interleukin-1β (IL-1β) stimulates several key mediators in the inflammatory response, it plays a major role in the pathogenesis of OA. Maslinic acid (MA) is a natural compound distributed in olive fruit. Previous studies have found that maslinic acid has an inhibitory effect on inflammation, but its specific role in the progression of OA disease has not been studied so far. In this study, we aim to assess the protective effect of MA on OA progression by in vitro and in vivo experiments. Our results indicate that, in IL-1β-induced inflammatory response, MA is effective in attenuating some major inflammatory mediators such as nitric oxide (NO) and prostaglandin E2, and inhibits the expression of IL-6, inducible nitric oxide synthase, cyclooxygenase-2, and tumor necrosis factor-α (TNF-α) in a concentration-dependent manner. Also, MA downregulated the expression levels of thrombospondin motif 5 (ADAMTS5) and matrix metalloproteinase 13 in chondrocytes, resulting in reduced degradation of its extracellular matrix. Mechanistically, MA exhibits an anti-inflammatory effect by inactivating the PI3K/AKT/NF-κB pathway. In vivo, the protective effect of MA on OA development can be detected in a surgically induced mouse OA model. In summary, these findings suggest that MA can be used as a safe and effective potential OA therapeutic strategy.Osteoarthritis (OA) is a degenerative joint disease characterized by destruction of articular cartilage. The inflammatory response is the most important factor affecting the disease process. As interleukin-1β (IL-1β) stimulates several key mediators in the inflammatory response, it plays a major role in the pathogenesis of OA. Maslinic acid (MA) is a natural compound distributed in olive fruit. Previous studies have found that maslinic acid has an inhibitory effect on inflammation, but its specific role in the progression of OA disease has not been studied so far. In this study, we aim to assess the protective effect of MA on OA progression by in vitro and in vivo experiments. Our results indicate that, in IL-1β-induced inflammatory response, MA is effective in attenuating some major inflammatory mediators such as nitric oxide (NO) and prostaglandin E2, and inhibits the expression of IL-6, inducible nitric oxide synthase, cyclooxygenase-2, and tumor necrosis factor-α (TNF-α) in a concentration-dependent manner. Also, MA downregulated the expression levels of thrombospondin motif 5 (ADAMTS5) and matrix metalloproteinase 13 in chondrocytes, resulting in reduced degradation of its extracellular matrix. Mechanistically, MA exhibits an anti-inflammatory effect by inactivating the PI3K/AKT/NF-κB pathway. In vivo, the protective effect of MA on OA development can be detected in a surgically induced mouse OA model. In summary, these findings suggest that MA can be used as a safe and effective potential OA therapeutic strategy.
Osteoarthritis (OA) is a degenerative joint disease characterized by destruction of articular cartilage. The inflammatory response is the most important factor affecting the disease process. As interleukin‐1β (IL‐1β) stimulates several key mediators in the inflammatory response, it plays a major role in the pathogenesis of OA. Maslinic acid (MA) is a natural compound distributed in olive fruit. Previous studies have found that maslinic acid has an inhibitory effect on inflammation, but its specific role in the progression of OA disease has not been studied so far. In this study, we aim to assess the protective effect of MA on OA progression by in vitro and in vivo experiments. Our results indicate that, in IL‐1β‐induced inflammatory response, MA is effective in attenuating some major inflammatory mediators such as nitric oxide (NO) and prostaglandin E2, and inhibits the expression of IL‐6, inducible nitric oxide synthase, cyclooxygenase‐2, and tumor necrosis factor‐α (TNF‐α) in a concentration‐dependent manner. Also, MA downregulated the expression levels of thrombospondin motif 5 (ADAMTS5) and matrix metalloproteinase 13 in chondrocytes, resulting in reduced degradation of its extracellular matrix. Mechanistically, MA exhibits an anti‐inflammatory effect by inactivating the PI3K/AKT/NF‐κB pathway. In vivo, the protective effect of MA on OA development can be detected in a surgically induced mouse OA model. In summary, these findings suggest that MA can be used as a safe and effective potential OA therapeutic strategy.
Osteoarthritis (OA) is a degenerative joint disease characterized by destruction of articular cartilage. The inflammatory response is the most important factor affecting the disease process. As interleukin‐1β (IL‐1β) stimulates several key mediators in the inflammatory response, it plays a major role in the pathogenesis of OA. Maslinic acid (MA) is a natural compound distributed in olive fruit. Previous studies have found that maslinic acid has an inhibitory effect on inflammation, but its specific role in the progression of OA disease has not been studied so far. In this study, we aim to assess the protective effect of MA on OA progression by in vitro and in vivo experiments. Our results indicate that, in IL‐1β‐induced inflammatory response, MA is effective in attenuating some major inflammatory mediators such as nitric oxide (NO) and prostaglandin E2, and inhibits the expression of IL‐6, inducible nitric oxide synthase, cyclooxygenase‐2, and tumor necrosis factor‐α (TNF‐α) in a concentration‐dependent manner. Also, MA downregulated the expression levels of thrombospondin motif 5 (ADAMTS5) and matrix metalloproteinase 13 in chondrocytes, resulting in reduced degradation of its extracellular matrix. Mechanistically, MA exhibits an anti‐inflammatory effect by inactivating the PI3K/AKT/NF‐κB pathway. In vivo, the protective effect of MA on OA development can be detected in a surgically induced mouse OA model. In summary, these findings suggest that MA can be used as a safe and effective potential OA therapeutic strategy. Maslinic acid (MA) could prevent IL‐1β‐associated inflammation as well as extracellular matrix (ECM) degradation in human osteoarthritis (OA) chondrocytes. The potential mechanism involved in the protective effect of MA was that it could reverse inflammation‐related destruction via inhibiting PI3K/AKT/NF‐κB pathways activation. MA ameliorates OA progression in vivo via inhibiting the devastation of cartilage surface, cartilage calcification, and osteophytes formation.
Author Hu, Zhi‐Chao
Bao, Guo‐Dong
Jin, Chen‐Qiang
Hu, Xin‐Li
Wu, Chen‐Yu
Shen, Zhong‐Hai
Ni, Wen‐Fei
Yan, De‐Yi
Xuan, Jiang‐Wei
Bian, Yu‐Jie
Chen, Yan‐Lin
Author_xml – sequence: 1
  givenname: Yan‐Lin
  orcidid: 0000-0002-4274-2980
  surname: Chen
  fullname: Chen, Yan‐Lin
  organization: The Key Orthopaedic Laboratory of Zhejiang Province
– sequence: 2
  givenname: De‐Yi
  surname: Yan
  fullname: Yan, De‐Yi
  organization: The Key Orthopaedic Laboratory of Zhejiang Province
– sequence: 3
  givenname: Chen‐Yu
  surname: Wu
  fullname: Wu, Chen‐Yu
  organization: The Key Orthopaedic Laboratory of Zhejiang Province
– sequence: 4
  givenname: Jiang‐Wei
  surname: Xuan
  fullname: Xuan, Jiang‐Wei
  organization: The Key Orthopaedic Laboratory of Zhejiang Province
– sequence: 5
  givenname: Chen‐Qiang
  surname: Jin
  fullname: Jin, Chen‐Qiang
  organization: The Key Orthopaedic Laboratory of Zhejiang Province
– sequence: 6
  givenname: Xin‐Li
  surname: Hu
  fullname: Hu, Xin‐Li
  organization: The Key Orthopaedic Laboratory of Zhejiang Province
– sequence: 7
  givenname: Guo‐Dong
  surname: Bao
  fullname: Bao, Guo‐Dong
  organization: The Key Orthopaedic Laboratory of Zhejiang Province
– sequence: 8
  givenname: Yu‐Jie
  surname: Bian
  fullname: Bian, Yu‐Jie
  organization: The Key Orthopaedic Laboratory of Zhejiang Province
– sequence: 9
  givenname: Zhi‐Chao
  surname: Hu
  fullname: Hu, Zhi‐Chao
  email: 764455268@qq.com
  organization: The Key Orthopaedic Laboratory of Zhejiang Province
– sequence: 10
  givenname: Zhong‐Hai
  surname: Shen
  fullname: Shen, Zhong‐Hai
  email: shenzhongh@163.com
  organization: The Second Affiliated Hospital of Jiaxing University
– sequence: 11
  givenname: Wen‐Fei
  orcidid: 0000-0001-8823-6402
  surname: Ni
  fullname: Ni, Wen‐Fei
  email: wenfeini@yeah.net
  organization: The Key Orthopaedic Laboratory of Zhejiang Province
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32730652$$D View this record in MEDLINE/PubMed
BookMark eNp1kcFO3DAQhi1EVRbaAy9QWeJSDmHtOInjI10V2LIUDnC2HNsRXiV2sB3Q3voIPAtHHoKH6JPU7S4XVC4z0sz3_xrNvwu2rbMagH2MjjBC-XQph6OcMUq3wAQjRrOiKvNtMEk7nLGywDtgN4QlQogxQj6CHZJTghIzAcOFCJ2xRkIhjYKD1_faxgDni9-_HvHLU6rGqlFqBY1tO9H3Ijq_gl6Hwdmg0xS6ELUTPt56E02A90bAqzk5nx6fX09_niSHl-dvcBDx9kGswifwoRVd0J83fQ_cnHy_np1li8vT-ex4kUlSEpoJ2ihFqZRCUkVqKbHCNW2aSrUStZrVqqxU3dZ5pXFVtZIWkpVNKUua15VSiOyBr2vfwbu7UYfIexOk7jphtRsDz4s8PaxgVZnQgzfo0o3epusSRTEtCKU4UV821Nj0WvHBm174FX_9ZQKma0B6F4LXLZcmimicjV6YjmPE_6bFU1r8X1pJcfhG8Wr6P3bj_mA6vXof5D9mV2vFH4LOqEY
CitedBy_id crossref_primary_10_3390_ani13061041
crossref_primary_10_1016_j_phymed_2022_154347
crossref_primary_10_1080_10408398_2024_2448768
crossref_primary_10_1186_s13018_021_02528_w
crossref_primary_10_1016_j_biopha_2022_114118
crossref_primary_10_2147_DDDT_S326328
crossref_primary_10_1016_j_jot_2021_05_004
crossref_primary_10_1016_j_bmc_2021_116494
crossref_primary_10_3390_molecules27248732
crossref_primary_10_3390_biomedicines13020376
crossref_primary_10_3390_foods10091993
crossref_primary_10_1186_s12938_021_00917_0
crossref_primary_10_1007_s11596_022_2657_6
crossref_primary_10_1016_j_intimp_2023_110453
crossref_primary_10_4155_fmc_2021_0127
crossref_primary_10_1016_j_intimp_2024_112435
crossref_primary_10_3389_fcvm_2021_768947
crossref_primary_10_1021_acsomega_1c06729
crossref_primary_10_3389_fphar_2021_669213
crossref_primary_10_3390_ijms22115722
crossref_primary_10_1155_2022_7000531
crossref_primary_10_3724_abbs_2024027
crossref_primary_10_1111_jocd_15730
crossref_primary_10_1186_s11658_024_00581_x
crossref_primary_10_1142_S0192415X2350043X
crossref_primary_10_3390_chemistry6050067
crossref_primary_10_1007_s12013_022_01083_3
crossref_primary_10_1186_s13018_023_04083_y
crossref_primary_10_3389_fphar_2021_708575
crossref_primary_10_1177_19476035231181446
crossref_primary_10_1007_s13273_023_00406_6
crossref_primary_10_1016_j_clim_2021_108889
crossref_primary_10_1016_j_yexcr_2024_114172
crossref_primary_10_1039_D0BM01932A
crossref_primary_10_1186_s12951_022_01598_0
crossref_primary_10_1371_journal_pone_0299351
crossref_primary_10_3389_fphar_2023_1067402
Cites_doi 10.1002/ptr.5877
10.1007/s12038-018-9745-6
10.1002/jbmr.242
10.1007/s12192-018-0956-4
10.1074/jbc.M706387200
10.1016/j.ejim.2012.10.002
10.1016/j.joca.2007.07.009
10.1016/j.joca.2006.04.008
10.3390/antiox9020106
10.1016/j.joca.2010.05.025
10.1016/j.ejphar.2011.09.175
10.3390/toxins8050155
10.1002/mnfr.201200481
10.1001/jama.2013.281053
10.1007/s10753-018-0753-3
10.1021/jf101022p
10.1002/art.23176
10.1016/S0006-2952(03)00420-9
10.1016/j.joca.2014.04.018
10.1089/ten.teb.2013.0377
10.1002/art.24857
10.1007/s12272-011-0113-4
10.1007/s10195-017-0473-8
10.1371/journal.pone.0162022
10.3390/biom5031266
10.1097/BOR.0b013e328349c2b1
10.1016/j.biopha.2017.09.001
10.1039/C6FO00613B
10.1016/j.joca.2007.03.006
10.1016/S0140-6736(14)60802-3
10.1172/JCI11914
10.1055/s-2003-39698
10.1136/bmj.38159.639028.7C
10.3164/jcbn.16-119
10.1016/j.biocel.2009.09.015
10.1080/10715760500467935
10.1101/cshperspect.a000216
10.1016/j.joca.2005.07.014
10.1038/sj.onc.1203224
10.1371/journal.pone.0194572
10.1016/j.ejphar.2013.01.057
10.1016/j.semarthrit.2013.07.003
10.1016/j.biopha.2017.01.130
10.1016/S0014-5793(03)00672-0
10.1038/sj.onc.1209954
ContentType Journal Article
Copyright 2020 Wiley Periodicals LLC
2020 Wiley Periodicals LLC.
Copyright_xml – notice: 2020 Wiley Periodicals LLC
– notice: 2020 Wiley Periodicals LLC.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TK
7U7
8FD
C1K
FR3
K9.
P64
RC3
7X8
DOI 10.1002/jcp.29977
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Neurosciences Abstracts
Toxicology Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
ProQuest Health & Medical Complete (Alumni)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Genetics Abstracts
Technology Research Database
Toxicology Abstracts
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
CrossRef
Genetics Abstracts
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Biology
EISSN 1097-4652
EndPage 1949
ExternalDocumentID 32730652
10_1002_jcp_29977
JCP29977
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Zhejiang Provincial Natural Science Foundation of China
  funderid: LY17H060009
– fundername: Wenzhou Municipal Science and Technology Bureau
  funderid: Y20190078
– fundername: Clinical Scientific Research Project of the Second Affiliated Hospital of the Wenzhou Medical University
  funderid: SAHoWMU‐CR2017‐08‐106
GroupedDBID ---
-DZ
-~X
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
31~
33P
36B
3O-
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5GY
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
85S
8UM
930
9M8
A03
AAESR
AAEVG
AAHHS
AAHQN
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDPE
ABEFU
ABEML
ABIJN
ABJNI
ABPPZ
ABPVW
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACNCT
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AIAGR
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AUFTA
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BQCPF
BROTX
BRXPI
BY8
CS3
D-E
D-F
DCZOG
DPXWK
DR1
DR2
DRFUL
DRSTM
DU5
EBD
EBS
EJD
EMB
EMOBN
F00
F01
F04
F5P
FEDTE
G-S
G.N
GNP
GODZA
H.T
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
H~9
IH2
IX1
J0M
JPC
KQQ
L7B
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M56
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MVM
MXFUL
MXSTM
N04
N05
N9A
NEJ
NF~
NNB
O66
O9-
OHT
OIG
P2P
P2W
P2X
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
ROL
RWI
RWR
RX1
RYL
S10
SAMSI
SUPJJ
SV3
TN5
TWZ
UB1
UPT
V2E
V8K
VQP
W8V
W99
WBKPD
WH7
WIB
WIH
WIK
WJL
WNSPC
WOHZO
WQJ
WRC
WXSBR
WYB
WYISQ
X7M
XG1
XJT
XOL
XPP
XSW
XV2
Y6R
YQT
YZZ
ZGI
ZXP
ZZTAW
~IA
~WT
AAYXX
ADXHL
AETEA
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TK
7U7
8FD
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
C1K
FR3
K9.
P64
RC3
7X8
ID FETCH-LOGICAL-c3537-a7bdd77ccac7d38cc1d187bb6dfc0fe98d56d8f826e166fc74c95b5c57286dd03
IEDL.DBID DR2
ISSN 0021-9541
1097-4652
IngestDate Thu Jul 10 17:36:15 EDT 2025
Sat Jul 26 00:47:49 EDT 2025
Thu Apr 03 07:06:46 EDT 2025
Tue Jul 01 03:23:42 EDT 2025
Thu Apr 24 22:55:15 EDT 2025
Wed Jan 22 16:31:35 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords PI3K/Akt/NF-κB
osteoarthritis
maslinic acid
Language English
License 2020 Wiley Periodicals LLC.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3537-a7bdd77ccac7d38cc1d187bb6dfc0fe98d56d8f826e166fc74c95b5c57286dd03
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-4274-2980
0000-0001-8823-6402
PMID 32730652
PQID 2471743771
PQPubID 1006363
PageCount 11
ParticipantIDs proquest_miscellaneous_2429774965
proquest_journals_2471743771
pubmed_primary_32730652
crossref_citationtrail_10_1002_jcp_29977
crossref_primary_10_1002_jcp_29977
wiley_primary_10_1002_jcp_29977_JCP29977
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate March 2021
2021-03-00
20210301
PublicationDateYYYYMMDD 2021-03-01
PublicationDate_xml – month: 03
  year: 2021
  text: March 2021
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hoboken
PublicationTitle Journal of cellular physiology
PublicationTitleAlternate J Cell Physiol
PublicationYear 2021
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2017; 61
2015; 5
2010; 58
2013; 708
2013; 43
2010; 18
2013; 24
2009; 60
2015; 386
2006; 14
2017; 89
2008; 58
2014; 24
2018; 41
2011; 34
2004; 329
2001; 107
2018; 43
2014; 22
2011; 672
2008; 283
2007; 15
2014; 20
2016; 11
2017; 95
2017; 31
2016; 7
2010; 42
2003; 547
2006; 40
1991; 26
2013; 57
1999; 18
2019; 24
2006; 25
2020; 9
2013; 310
2003; 69
2011; 23
2017; 18
2011; 26
2010; 2
2018; 16
2016; 8
2003; 66
2018; 13
e_1_2_8_28_1
e_1_2_8_29_1
e_1_2_8_24_1
e_1_2_8_47_1
e_1_2_8_25_1
e_1_2_8_46_1
e_1_2_8_27_1
e_1_2_8_48_1
Zou Z. M. (e_1_2_8_49_1) 1991; 26
e_1_2_8_3_1
e_1_2_8_2_1
e_1_2_8_5_1
e_1_2_8_4_1
e_1_2_8_7_1
e_1_2_8_6_1
e_1_2_8_9_1
e_1_2_8_8_1
e_1_2_8_20_1
e_1_2_8_43_1
e_1_2_8_21_1
e_1_2_8_42_1
e_1_2_8_22_1
e_1_2_8_45_1
e_1_2_8_23_1
e_1_2_8_44_1
e_1_2_8_41_1
e_1_2_8_40_1
e_1_2_8_17_1
e_1_2_8_18_1
e_1_2_8_39_1
e_1_2_8_19_1
e_1_2_8_13_1
e_1_2_8_36_1
e_1_2_8_14_1
e_1_2_8_35_1
e_1_2_8_38_1
e_1_2_8_16_1
e_1_2_8_37_1
e_1_2_8_32_1
e_1_2_8_10_1
e_1_2_8_31_1
e_1_2_8_11_1
e_1_2_8_34_1
e_1_2_8_12_1
e_1_2_8_33_1
Gross J. B. (e_1_2_8_15_1) 2014; 24
Li H. (e_1_2_8_26_1) 2018; 16
e_1_2_8_30_1
References_xml – volume: 60
  start-page: 2985
  issue: 10
  year: 2009
  end-page: 2996
  article-title: Mechanical injury potentiates proteoglycan catabolism induced by interleukin‐6 with soluble interleukin‐6 receptor and tumor necrosis factor alpha in immature bovine and adult human articular cartilage
  publication-title: Arthtitis and Rheumatism
– volume: 2
  issue: 1
  year: 2010
  article-title: The regulatory logic of the NF‐kappaB signaling system
  publication-title: Cold Spring Harbor Perspectives in Biology
– volume: 708
  start-page: 1
  issue: 1‐3
  year: 2013
  end-page: 7
  article-title: Celastrol, an inhibitor of heat shock protein 90beta potently suppresses the expression of matrix metalloproteinases, inducible nitric oxide synthase and cyclooxygenase‐2 in primary human osteoarthritic chondrocytes
  publication-title: European Journal of Pharmacology
– volume: 26
  start-page: 644
  issue: 3
  year: 2011
  end-page: 656
  article-title: Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy‐induced bone loss by regulating RANKL‐mediated NF‐kappaB and MAPK signaling pathways
  publication-title: Journal of Bone and Mineral Research
– volume: 25
  start-page: 6680
  issue: 51
  year: 2006
  end-page: 6684
  article-title: Introduction to NF‐kappaB: Players, pathways, perspectives
  publication-title: Oncogene
– volume: 24
  start-page: 11
  issue: 1
  year: 2013
  end-page: 15
  article-title: Serological markers of erosive hand osteoarthritis
  publication-title: European Journal of Internal Medicine
– volume: 41
  start-page: 996
  issue: 3
  year: 2018
  end-page: 1007
  article-title: Nobiletin‐ameliorated lipopolysaccharide‐induced inflammation in acute lung injury by suppression of NF‐kappaB pathway in vivo and vitro
  publication-title: Inflammation
– volume: 18
  start-page: 349
  issue: 4
  year: 2017
  end-page: 357
  article-title: Circulating levels of proinflammatory mediators as potential biomarkers of post‐traumatic knee osteoarthritis development
  publication-title: Journal of Orthopaedics and Traumatology
– volume: 16
  start-page: 4737
  issue: 6
  year: 2018
  end-page: 4744
  article-title: TNF‐alpha increases the expression of inflammatory factors in synovial fibroblasts by inhibiting the PI3K/AKT pathway in a rat model of monosodium iodoacetate‐induced osteoarthritis
  publication-title: Experimental and Therapeutic Medicine
– volume: 24
  start-page: 195
  issue: 1
  year: 2019
  end-page: 202
  article-title: PI3K/Akt and caspase pathways mediate oxidative stress‐induced chondrocyte apoptosis
  publication-title: Cell Stress and Chaperones
– volume: 107
  start-page: 135
  issue: 2
  year: 2001
  end-page: 142
  article-title: Therapeutic potential of inhibition of the NF‐kappaB pathway in the treatment of inflammation and cancer
  publication-title: Journal of Clinical Investigation
– volume: 7
  start-page: 2870
  issue: 6
  year: 2016
  end-page: 2877
  article-title: Chemical characterization of the main bioactive constituents from fruits of
  publication-title: Food & Function
– volume: 13
  issue: 3
  year: 2018
  article-title: Evaluation of maslinic acid with whole‐body vibration training in elderly women with knee osteoarthritis
  publication-title: PLOS One
– volume: 43
  start-page: 303
  issue: 3
  year: 2013
  end-page: 313
  article-title: Health economics in the field of osteoarthritis: An expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)
  publication-title: Seminars in Arthritis and Rheumatism
– volume: 15
  start-page: 1061
  issue: 9
  year: 2007
  end-page: 1069
  article-title: The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse
  publication-title: Osteoarthritis and Cartilage
– volume: 42
  start-page: 198
  issue: 2
  year: 2010
  end-page: 201
  article-title: Prostaglandin E2 at new glance: Novel insights in functional diversity offer therapeutic chances
  publication-title: International Journal of Biochemistry and Cell Biology
– volume: 34
  start-page: 109
  issue: 1
  year: 2011
  end-page: 117
  article-title: Matrix metalloproteinase‐13 expression in IL‐1beta‐treated chondrocytes by activation of the p38 MAPK/c‐Fos/AP‐1 and JAK/STAT pathways
  publication-title: Archives of Pharmacal Research
– volume: 9
  issue: 2
  year: 2020
  article-title: Maslinic acid ameliorates inflammation via the downregulation of NF‐kappaB and STAT‐1
  publication-title: Antioxidants
– volume: 547
  start-page: 75
  issue: 1–3
  year: 2003
  end-page: 79
  article-title: IL‐1beta‐dependent activation of NF‐kappaB mediates PGE2 release via the expression of cyclooxygenase‐2 and microsomal prostaglandin E synthase
  publication-title: FEBS Letters
– volume: 69
  start-page: 472
  issue: 5
  year: 2003
  end-page: 474
  article-title: Antioxidant activity of maslinic acid, a triterpene derivative obtained from
  publication-title: Planta Medica
– volume: 89
  start-page: 1252
  year: 2017
  end-page: 1261
  article-title: Inhibition of PI3K/AKT/mTOR signaling pathway promotes autophagy of articular chondrocytes and attenuates inflammatory response in rats with osteoarthritis
  publication-title: Biomedicine & Pharmacotherapy
– volume: 95
  start-page: 904
  year: 2017
  end-page: 913
  article-title: Maslinic acid inhibits impairment of endothelial functions induced by high glucose in HAEC cells through improving insulin signaling and oxidative stress
  publication-title: Biomedicine & Pharmacotherapy
– volume: 18
  start-page: S17
  issue: Suppl. 3
  year: 2010
  end-page: S23
  article-title: The OARSI histopathology initiative—Recommendations for histological assessments of osteoarthritis in the mouse
  publication-title: Osteoarthritis and Cartilage
– volume: 14
  start-page: 13
  issue: 1
  year: 2006
  end-page: 29
  article-title: Osteoarthritis cartilage histopathology: Grading and staging
  publication-title: Osteoarthritis and Cartilage
– volume: 57
  start-page: 339
  issue: 2
  year: 2013
  end-page: 346
  article-title: Assessment of the safety of maslinic acid, a bioactive compound from L
  publication-title: Molecular Nutrition & Food Research
– volume: 8
  issue: 5
  year: 2016
  article-title: ADAM and ADAMTS family proteins and snake venom metalloproteinases: A structural overview
  publication-title: Toxins
– volume: 26
  start-page: 906
  issue: 12
  year: 1991
  end-page: 910
  article-title: Studies on the chemical constituents from roots of
  publication-title: Yao Xue Xue Bao
– volume: 329
  start-page: 324
  issue: 7461
  year: 2004
  article-title: Efficacy of topical non‐steroidal anti‐inflammatory drugs in the treatment of osteoarthritis: Meta‐analysis of randomised controlled trials
  publication-title: BMJ
– volume: 43
  start-page: 277
  issue: 2
  year: 2018
  end-page: 285
  article-title: Maslinic acid modulates secreted phospholipase A2‐IIA (sPLA2‐IIA)‐mediated inflammatory effects in macrophage foam cells formation
  publication-title: Journal of Biosciences
– volume: 61
  start-page: 67
  issue: 1
  year: 2017
  end-page: 73
  article-title: Maslinic acid improves quality of life by alleviating joint knee pain in the elderly: Results from a community‐based pilot study
  publication-title: Journal of Clinical Biochemistry and Nutrition
– volume: 310
  start-page: 2191
  issue: 20
  year: 2013
  end-page: 2194
  article-title: World medical association declaration of Helsinki: Ethical principles for medical research involving human subjects
  publication-title: Journal of the American Medical Association
– volume: 58
  start-page: 26
  issue: 1
  year: 2008
  end-page: 35
  article-title: Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II
  publication-title: Arthtitis and Rheumatism
– volume: 14
  start-page: 839
  issue: 9
  year: 2006
  end-page: 848
  article-title: NF‐kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis
  publication-title: Osteoarthritis and Cartilage
– volume: 22
  start-page: 933
  issue: 7
  year: 2014
  end-page: 940
  article-title: Knee pain and inflammation in the infrapatellar fat pad estimated by conventional and dynamic contrast‐enhanced magnetic resonance imaging in obese patients with osteoarthritis: A cross‐sectional study
  publication-title: Osteoarthritis and Cartilage
– volume: 18
  start-page: 6845
  issue: 49
  year: 1999
  end-page: 6852
  article-title: Regulation of DNA binding by Rel/NF‐kappaB transcription factors: Structural views
  publication-title: Oncogene
– volume: 11
  issue: 9
  year: 2016
  article-title: Shea nut oil triterpene concentrate attenuates knee osteoarthritis development in rats: Evidence from knee joint histology
  publication-title: PLOS One
– volume: 31
  start-page: 1457
  issue: 9
  year: 2017
  end-page: 1460
  article-title: Bioactive triterpenes from the root of salvia miltiorrhiza bunge
  publication-title: Phytotherapy Research
– volume: 5
  start-page: 1266
  issue: 3
  year: 2015
  end-page: 1283
  article-title: NF‐kappaB signaling in chronic inflammatory airway disease
  publication-title: Biomolecules
– volume: 40
  start-page: 295
  issue: 3
  year: 2006
  end-page: 302
  article-title: Supressive effect of maslinic acid from pomace olive oil on oxidative stress and cytokine production in stimulated murine macrophages
  publication-title: Free Radical Research
– volume: 386
  start-page: 376
  issue: 9991
  year: 2015
  end-page: 387
  article-title: Osteoarthritis
  publication-title: Lancet
– volume: 24
  start-page: 17
  issue: 1 Suppl.
  year: 2014
  end-page: 25
  article-title: Synovial fluid levels of adipokines in osteoarthritis: Association with local factors of inflammation and cartilage maintenance
  publication-title: Biomedical Materials and Engineering
– volume: 23
  start-page: 471
  issue: 5
  year: 2011
  end-page: 478
  article-title: Inflammation in osteoarthritis
  publication-title: Current Opinion in Rheumatology
– volume: 283
  start-page: 4850
  issue: 8
  year: 2008
  end-page: 4865
  article-title: Interleukin‐6 (IL‐6) and/or soluble IL‐6 receptor down‐regulation of human type II collagen gene expression in articular chondrocytes requires a decrease of Sp1.Sp3 ratio and of the binding activity of both factors to the COL2A1 promoter
  publication-title: Journal of Biological Chemistry
– volume: 672
  start-page: 169
  issue: 1‐3
  year: 2011
  end-page: 174
  article-title: Anti‐inflammatory effects of maslinic acid, a natural triterpene, in cultured cortical astrocytes via suppression of nuclear factor‐kappa B
  publication-title: European Journal of Pharmacology
– volume: 20
  start-page: 355
  issue: 4
  year: 2014
  end-page: 363
  article-title: The roles of catabolic factors in the development of osteoarthritis
  publication-title: Tissue Engineering. Part B, Reviews
– volume: 58
  start-page: 6285
  issue: 10
  year: 2010
  end-page: 6289
  article-title: Characterization of triterpenic acids in fruits of ziziphus species by HPLC‐ELSD‐MS
  publication-title: Journal of Agricultural and Food Chemistry
– volume: 66
  start-page: 1055
  issue: 6
  year: 2003
  end-page: 1060
  article-title: Role of cyclooxygenase‐2, but not cyclooxygenase‐1, on type II collagen‐induced arthritis in DBA/1J mice
  publication-title: Biochemical Pharmacology
– volume: 15
  start-page: 1249
  issue: 11
  year: 2007
  end-page: 1255
  article-title: Avocado soybean unsaponifiables (ASU) suppress TNF‐alpha, IL‐1beta, COX‐2, iNOS gene expression, and prostaglandin E2 and nitric oxide production in articular chondrocytes and monocyte/macrophages
  publication-title: Osteoarthritis and Cartilage
– ident: e_1_2_8_43_1
  doi: 10.1002/ptr.5877
– ident: e_1_2_8_47_1
  doi: 10.1007/s12038-018-9745-6
– ident: e_1_2_8_23_1
  doi: 10.1002/jbmr.242
– ident: e_1_2_8_24_1
  doi: 10.1007/s12192-018-0956-4
– ident: e_1_2_8_35_1
  doi: 10.1074/jbc.M706387200
– ident: e_1_2_8_37_1
  doi: 10.1016/j.ejim.2012.10.002
– ident: e_1_2_8_2_1
  doi: 10.1016/j.joca.2007.07.009
– ident: e_1_2_8_38_1
  doi: 10.1016/j.joca.2006.04.008
– ident: e_1_2_8_21_1
  doi: 10.3390/antiox9020106
– ident: e_1_2_8_12_1
  doi: 10.1016/j.joca.2010.05.025
– ident: e_1_2_8_18_1
  doi: 10.1016/j.ejphar.2011.09.175
– ident: e_1_2_8_42_1
  doi: 10.3390/toxins8050155
– ident: e_1_2_8_39_1
  doi: 10.1002/mnfr.201200481
– ident: e_1_2_8_44_1
  doi: 10.1001/jama.2013.281053
– ident: e_1_2_8_27_1
  doi: 10.1007/s10753-018-0753-3
– ident: e_1_2_8_16_1
  doi: 10.1021/jf101022p
– ident: e_1_2_8_20_1
  doi: 10.1002/art.23176
– ident: e_1_2_8_33_1
  doi: 10.1016/S0006-2952(03)00420-9
– ident: e_1_2_8_4_1
  doi: 10.1016/j.joca.2014.04.018
– ident: e_1_2_8_5_1
  doi: 10.1089/ten.teb.2013.0377
– ident: e_1_2_8_41_1
  doi: 10.1002/art.24857
– ident: e_1_2_8_28_1
  doi: 10.1007/s12272-011-0113-4
– ident: e_1_2_8_34_1
  doi: 10.1007/s10195-017-0473-8
– ident: e_1_2_8_19_1
  doi: 10.1371/journal.pone.0162022
– ident: e_1_2_8_40_1
  doi: 10.3390/biom5031266
– ident: e_1_2_8_14_1
  doi: 10.1097/BOR.0b013e328349c2b1
– ident: e_1_2_8_25_1
  doi: 10.1016/j.biopha.2017.09.001
– ident: e_1_2_8_3_1
  doi: 10.1039/C6FO00613B
– ident: e_1_2_8_11_1
  doi: 10.1016/j.joca.2007.03.006
– ident: e_1_2_8_13_1
  doi: 10.1016/S0140-6736(14)60802-3
– ident: e_1_2_8_46_1
  doi: 10.1172/JCI11914
– ident: e_1_2_8_31_1
  doi: 10.1055/s-2003-39698
– ident: e_1_2_8_29_1
  doi: 10.1136/bmj.38159.639028.7C
– ident: e_1_2_8_9_1
  doi: 10.3164/jcbn.16-119
– ident: e_1_2_8_22_1
  doi: 10.1016/j.biocel.2009.09.015
– ident: e_1_2_8_30_1
  doi: 10.1080/10715760500467935
– ident: e_1_2_8_32_1
  doi: 10.1101/cshperspect.a000216
– ident: e_1_2_8_36_1
  doi: 10.1016/j.joca.2005.07.014
– volume: 16
  start-page: 4737
  issue: 6
  year: 2018
  ident: e_1_2_8_26_1
  article-title: TNF‐alpha increases the expression of inflammatory factors in synovial fibroblasts by inhibiting the PI3K/AKT pathway in a rat model of monosodium iodoacetate‐induced osteoarthritis
  publication-title: Experimental and Therapeutic Medicine
– volume: 26
  start-page: 906
  issue: 12
  year: 1991
  ident: e_1_2_8_49_1
  article-title: Studies on the chemical constituents from roots of Agastache rugosa
  publication-title: Yao Xue Xue Bao
– ident: e_1_2_8_7_1
  doi: 10.1038/sj.onc.1203224
– ident: e_1_2_8_48_1
  doi: 10.1371/journal.pone.0194572
– ident: e_1_2_8_8_1
  doi: 10.1016/j.ejphar.2013.01.057
– ident: e_1_2_8_17_1
  doi: 10.1016/j.semarthrit.2013.07.003
– ident: e_1_2_8_45_1
  doi: 10.1016/j.biopha.2017.01.130
– volume: 24
  start-page: 17
  issue: 1
  year: 2014
  ident: e_1_2_8_15_1
  article-title: Synovial fluid levels of adipokines in osteoarthritis: Association with local factors of inflammation and cartilage maintenance
  publication-title: Biomedical Materials and Engineering
– ident: e_1_2_8_6_1
  doi: 10.1016/S0014-5793(03)00672-0
– ident: e_1_2_8_10_1
  doi: 10.1038/sj.onc.1209954
SSID ssj0009933
Score 2.506911
Snippet Osteoarthritis (OA) is a degenerative joint disease characterized by destruction of articular cartilage. The inflammatory response is the most important factor...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1939
SubjectTerms 1-Phosphatidylinositol 3-kinase
Aged
AKT protein
Animals
Arthritis
Biomedical materials
Cartilage
Cartilage (articular)
Cartilage diseases
Cell Survival - drug effects
Chondrocytes
Chondrocytes - drug effects
Chondrocytes - metabolism
Chondrocytes - pathology
Collagenase 3
Cyclooxygenase 2 - metabolism
Dinoprostone - metabolism
Disease Models, Animal
Extracellular matrix
Extracellular Matrix - drug effects
Extracellular Matrix - metabolism
Female
Humans
Inflammation
Inflammation - complications
Inflammation - prevention & control
Inflammatory response
Interleukin-1beta - adverse effects
Interleukin-6 - metabolism
Interleukins
Joint diseases
Male
maslinic acid
Matrix metalloproteinase
Matrix metalloproteinases
Mice
Mice, Inbred C57BL
Models, Biological
NF-kappa B - metabolism
NF-KappaB Inhibitor alpha - metabolism
Nitric oxide
Nitric Oxide - metabolism
Nitric Oxide Synthase Type II - metabolism
Nitric-oxide synthase
Osteoarthritis
Osteoarthritis - drug therapy
Osteoarthritis - metabolism
Pathogenesis
Phosphatidylinositol 3-Kinases - metabolism
PI3K/Akt/NF‐κB
Prostaglandin E2
Prostaglandin endoperoxide synthase
Protein Transport - drug effects
Proteolysis - drug effects
Proto-Oncogene Proteins c-akt - metabolism
Signal Transduction
Thrombospondin
Transcription Factor RelA - metabolism
Triterpenes - chemistry
Triterpenes - pharmacology
Triterpenes - therapeutic use
Tumor necrosis factor
Tumor Necrosis Factor-alpha - metabolism
Tumor necrosis factor-TNF
Title Maslinic acid prevents IL‐1β‐induced inflammatory response in osteoarthritis via PI3K/AKT/NF‐κB pathways
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjcp.29977
https://www.ncbi.nlm.nih.gov/pubmed/32730652
https://www.proquest.com/docview/2471743771
https://www.proquest.com/docview/2429774965
Volume 236
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFL2qKiGx4dHyGCjIIITYZCZ24jgRq1IxagutKkSlLpAiP0WBZkbNDNV0xSfwLSz5iH5Ev6TXzqMqDwmxiaLEiRPnXPvYufdcgGdGuNgJriITKxulKRORUlpF2mVFomkq87DesbObbe6n2wf8YAledrEwjT5Ev-DmLSP0197ApapHl6Khn_R0iH2p8JHk3lfLE6J3l9JRRZtGPrgg8JR2qkIxG_VXXh2LfiOYV_lqGHDGN-FD96iNn8nn4Xymhvr0FxXH_3yXW3CjJaJkvUHObViy1Qqsrlc4CT9akOckuIaGNfcVuNZkrFyswnRH1iGWkkh9aMi0EYCqydbb82_f6dkP3OIkH-FiCEIX0XYU_uKT48YV1-JR4sNKJojYj0FPiXw9lGRvK3kzQro52h3jHc5-viI-U_KJXNR3YH_8-v3GZtQmbYh0whMRSaGMEQKBoYVJcq2poblQKjNOx84WueGZyR3OaizNfKBRqguuuOaC5ZkxcXIXlqtJZe8D0cxSbaxjVto0py5HaqOl0JlylMVGDeBF9_lK3Sqa-8QaX8pGi5mV2K5laNcBPO2LThsZjz8VWuswULaWXJcMR29kWULQATzpT6MN-h8rsrKTuS_DPI0uMj6Aew12-loS5IdI8xg-bEDA36svtzf2ws6Dfy_6EK4zj_DgFLcGy7PjuX2ELGmmHgdzuABFAhPI
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFL0qRQg2PFoeUwoYhBCbzMTOw4nUTSmMZtqZUYVaqRsU-RW1hWZGnZmiYcUn8C1d8hH9CL6Ea-dRlYeE2ERR4sSOc659bF-fC_BS89zPeSQ97UvjhSHjnpRKeiqP00DRUCRuvmM4inv74fZBdLAEG_VemFIfoplws5bh2mtr4HZCunOpGnqsJm1sTDm_BtdtRG-rnP_2_aV4VFoFkndOCFFIa10hn3WaR6_2Rr9RzKuM1XU53TvwoS5s6WnysT2fybb68ouO4_9-zV24XXFRslmC5x4smWIFVjcLHIefLMgr4rxD3bT7Ctwog1YuVmEyFFO3nZIIdaTJpNSAmpL-4MfXb_TiHI84zkfEaILoRcCduIV8clp64xq8SuzOkjGC9tBJKpGzI0F2-8FOBxlnZ9TFN1x8f0NssOTPYjG9D_vdd3tbPa-K2-CpIAq4J7jUmnPEhuI6SJSimiZcyljnys9Nmugo1kmOAxtDY7vXKFRpJCMVcZbEWvvBA1guxoV5BEQxQ5U2OTPChAnNE2Q3SnAVy5wyX8sWvK7_X6YqUXMbW-NTVsoxswzrNXP12oIXTdJJqeTxp0TrNQiyypinGcMOHIkW57QFz5vbaIZ2bUUUZjy3aZhl0mkcteBhCZ4mlwApIjI9hoV1EPh79tn21q47Wfv3pM_gZm9vOMgG_dHOY7jFLNydj9w6LM9O5-YJkqaZfOps4ydchBfk
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ZbtQwFL0qRSBeWFqWKQUMQoiXzMTO4kR9Ki2jTpfRCFGpD0hRvKktNBN1ZoqGJz6Bb-kjH9GP4Eu4dpaqLBLiJYoSJ3acc-1j-_pcgJeKG9_wSHjKF9oLQ8Y9IaTwpInTQNIwT9x8x94w3toPtw-igwVYa_bCVPoQ7YSbtQzXXlsDL5XpXYqGHsuyi20p59fgehj7qY3bsPnuUjsqrePIOx-EKKSNrJDPeu2jVzuj3xjmVcLqepz-HfjQlLVyNPnYnU1FV375RcbxPz_mLtyumShZr6BzDxZ0sQTL6wWOwk_m5BVxvqFu0n0JblQhK-fLUO7lE7eZkuTySJGyUoCakMHuj6_f6MU5HnGUj3hRBLGLcDtxy_jktPLF1XiV2H0lY4TsoRNUImdHORkNgp0e8s3esI9vuPj-hthQyZ_z-eQ-7Pffvt_Y8uqoDZ4MooB7ORdKcY7IkFwFiZRU0YQLESsjfaPTREWxSgwOazSN7U6jUKaRiGTEWRIr5QcPYLEYF_oREMk0lUobpnMdJtQkyG1kzmUsDGW-Eh143fy-TNaS5jayxqesEmNmGdZr5uq1Ay_apGWl4_GnRKsNBrLalCcZw-4baRbntAPP29tohHZlJS_0eGbTMMuj0zjqwMMKO20uARJE5HkMC-sQ8Pfss-2NkTtZ-fekz-DmaLOf7Q6GO4_hFrNgdw5yq7A4PZ3pJ8iYpuKps4yfFrMWkw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Maslinic+acid+prevents+IL%E2%80%901%CE%B2%E2%80%90induced+inflammatory+response+in+osteoarthritis+via+PI3K%2FAKT%2FNF%E2%80%90%CE%BAB+pathways&rft.jtitle=Journal+of+cellular+physiology&rft.au=Chen%2C+Yan%E2%80%90Lin&rft.au=Yan%2C+De%E2%80%90Yi&rft.au=Wu%2C+Chen%E2%80%90Yu&rft.au=Xuan%2C+Jiang%E2%80%90Wei&rft.date=2021-03-01&rft.issn=0021-9541&rft.eissn=1097-4652&rft.volume=236&rft.issue=3&rft.spage=1939&rft.epage=1949&rft_id=info:doi/10.1002%2Fjcp.29977&rft.externalDBID=10.1002%252Fjcp.29977&rft.externalDocID=JCP29977
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9541&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9541&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9541&client=summon